基于连续血糖监测预测 1 型糖尿病患者每周低血糖风险的机器学习模型的开发与验证。

IF 5.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Diabetes technology & therapeutics Pub Date : 2024-07-01 Epub Date: 2024-05-29 DOI:10.1089/dia.2023.0532
Simon Lebech Cichosz, Morten Hasselstrøm Jensen, Søren Schou Olesen
{"title":"基于连续血糖监测预测 1 型糖尿病患者每周低血糖风险的机器学习模型的开发与验证。","authors":"Simon Lebech Cichosz, Morten Hasselstrøm Jensen, Søren Schou Olesen","doi":"10.1089/dia.2023.0532","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Aim:</i></b> The aim of this study was to develop and validate a prediction model based on continuous glucose monitoring (CGM) data to identify a week-to-week risk profile of excessive hypoglycemia. <b><i>Methods:</i></b> We analyzed, trained, and internally tested two prediction models using CGM data from 205 type 1 diabetes patients with long-term CGM monitoring. A binary classification approach (XGBoost) combined with feature engineering deployed on the CGM signals was utilized to predict excessive hypoglycemia risk defined by two targets (time below range [TBR] >4% and the upper TBR 90th percentile limit) of TBR the following week. The models were validated in two independent cohorts with a total of 253 additional patients. <b><i>Results:</i></b> A total of 61,470 weeks of CGM data were included in the analysis. The XGBoost models had an area under the receiver operating characteristic curve (ROC-AUC) of 0.83-0.87 (95% confidence interval; 0.83-0.88) in the test dataset. The external validation showed ROC-AUCs of 0.81-0.90. The most discriminative features included the low blood glucose index, the glycemic risk assessment diabetes equation (GRADE), hypoglycemia, the TBR, waveform length, the coefficient of variation and mean glucose during the previous week. This highlights that the pattern of hypoglycemia combined with glucose variability during the past week contains information on the risk of future hypoglycemia. <b><i>Conclusion:</i></b> Prediction models based on real-world CGM data can be used to predict the risk of hypoglycemia in the forthcoming week. The models showed good performance in both the internal and external validation cohorts.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":null,"pages":null},"PeriodicalIF":5.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Continuous Glucose Monitoring.\",\"authors\":\"Simon Lebech Cichosz, Morten Hasselstrøm Jensen, Søren Schou Olesen\",\"doi\":\"10.1089/dia.2023.0532\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Aim:</i></b> The aim of this study was to develop and validate a prediction model based on continuous glucose monitoring (CGM) data to identify a week-to-week risk profile of excessive hypoglycemia. <b><i>Methods:</i></b> We analyzed, trained, and internally tested two prediction models using CGM data from 205 type 1 diabetes patients with long-term CGM monitoring. A binary classification approach (XGBoost) combined with feature engineering deployed on the CGM signals was utilized to predict excessive hypoglycemia risk defined by two targets (time below range [TBR] >4% and the upper TBR 90th percentile limit) of TBR the following week. The models were validated in two independent cohorts with a total of 253 additional patients. <b><i>Results:</i></b> A total of 61,470 weeks of CGM data were included in the analysis. The XGBoost models had an area under the receiver operating characteristic curve (ROC-AUC) of 0.83-0.87 (95% confidence interval; 0.83-0.88) in the test dataset. The external validation showed ROC-AUCs of 0.81-0.90. The most discriminative features included the low blood glucose index, the glycemic risk assessment diabetes equation (GRADE), hypoglycemia, the TBR, waveform length, the coefficient of variation and mean glucose during the previous week. This highlights that the pattern of hypoglycemia combined with glucose variability during the past week contains information on the risk of future hypoglycemia. <b><i>Conclusion:</i></b> Prediction models based on real-world CGM data can be used to predict the risk of hypoglycemia in the forthcoming week. The models showed good performance in both the internal and external validation cohorts.</p>\",\"PeriodicalId\":11159,\"journal\":{\"name\":\"Diabetes technology & therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes technology & therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/dia.2023.0532\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/dia.2023.0532","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在开发和验证基于 CGM 数据的预测模型,以确定每周过度低血糖的风险概况:我们利用 205 名长期接受 CGM 监测的 1 型糖尿病患者的 CGM 数据分析、训练并内部测试了两个预测模型。我们利用二元分类方法(XGBoost)结合在 CGM 信号上部署的特征工程来预测下周低于血糖范围时间(TBR)的两个目标(TBR > 4% 和 TBR 第 90 百分位数上限)所定义的过度低血糖风险。这些模型在两个独立的队列中进行了验证,共增加了 253 名患者:共有 61470 周的 CGM 数据被纳入分析。在测试数据集中,XGBoost 模型的 ROC-AUC 为 0.83-0.87(95% 置信区间 [CI];0.83-0.88)。外部验证的 ROC-AUC 为 0.81-0.90。最具鉴别力的特征包括低血糖指数(LBGI)、血糖风险评估糖尿病方程(GRADE)、低血糖、TBR、波形长度、CV 和前一周的平均血糖。这突出表明,过去一周的低血糖模式与血糖变异性相结合,包含了未来低血糖风险的信息:结论:基于真实世界 CGM 数据的预测模型可用于预测未来一周的低血糖风险。这些模型在内部和外部验证队列中都表现出了良好的性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Continuous Glucose Monitoring.

Aim: The aim of this study was to develop and validate a prediction model based on continuous glucose monitoring (CGM) data to identify a week-to-week risk profile of excessive hypoglycemia. Methods: We analyzed, trained, and internally tested two prediction models using CGM data from 205 type 1 diabetes patients with long-term CGM monitoring. A binary classification approach (XGBoost) combined with feature engineering deployed on the CGM signals was utilized to predict excessive hypoglycemia risk defined by two targets (time below range [TBR] >4% and the upper TBR 90th percentile limit) of TBR the following week. The models were validated in two independent cohorts with a total of 253 additional patients. Results: A total of 61,470 weeks of CGM data were included in the analysis. The XGBoost models had an area under the receiver operating characteristic curve (ROC-AUC) of 0.83-0.87 (95% confidence interval; 0.83-0.88) in the test dataset. The external validation showed ROC-AUCs of 0.81-0.90. The most discriminative features included the low blood glucose index, the glycemic risk assessment diabetes equation (GRADE), hypoglycemia, the TBR, waveform length, the coefficient of variation and mean glucose during the previous week. This highlights that the pattern of hypoglycemia combined with glucose variability during the past week contains information on the risk of future hypoglycemia. Conclusion: Prediction models based on real-world CGM data can be used to predict the risk of hypoglycemia in the forthcoming week. The models showed good performance in both the internal and external validation cohorts.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
期刊最新文献
Safety of Options to "Boost" (Enhancing Insulin Infusion Rates) and "Ease-Off" (Reducing Insulin Infusion Rates) in CamAPS FX Hybrid Closed-Loop System: A Real-World Analysis. Clinical Utility of Serum C-peptide Concentration for Hospitalized Patients with Hyperglycemia. An Automated Insulin Delivery System with Automatic Meal Bolus Based on a Hand-Gesturing Algorithm. Noninvasive Real-Time Glucose Monitoring Is in the Near Future. Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1